{"disease":{"id":"ros1-fusion-positive-tumor","name":"ros1 fusion positive tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07122882","title":"Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":40,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03497624","title":"ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Addario Lung Cancer Medical Institute","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}